The Centers for Medicare & Medicaid Services and the Office of the National Coordinator for Health Information Technology (ONC) are seeking public comment on two regulations that lay a foundation for improving quality, efficiency, and safety through meaningful use of certified EHR technology, the agencies said.
Congress recently approved $1.6 million in funding for a research program aimed at developing novel imagining technologies for early prostate cancer detection.
Sexual function in prostate cancer patients receiving external beam radiation therapy (EBRT) decreases within the first 2 years after treatment but then stabilizes and does not continuously decline as was previously thought, according to a recently published study.
A complete evaluation, including an assessment of post-void residual volume, is key when evaluating a female patient for surgery to treat stress urinary incontinence (SUI), according to a new clinical practice guideline released by AUA.
Submucosal injection of the steroid triamcinolone (Kenalog) is a safe, effective alternative to fulguration or laser ablation for treating Hunner's ulcers in interstitial cystitis patients.
Once again, urologists have had to face the prospects of huge reductions in their Medicare reimbursement rates because of the inability of Congress to resolve the problems imposed by the sustainable growth rate (SGR) formula, and once again, they must count on a temporary reprieve.
Unfortunately, there is no code for "history of elevated PSA."
In patients with locally advanced prostate cancer, overall survival is improved with 3 years of long-term adjuvant androgen deprivation and external radiation therapy, without an apparent increase in cardiovascular toxicity, according to 10-year findings.
Physicians who treat men with prostate cancer encounter difficult choices, often because data from properly conducted studies are lacking.
Long-term, reliable use of antimuscarinics in patients with overactive bladder is significantly lower than past clinical trials have suggested.
Urologists share their plans for their practices for 2010.
Estate planning strategies utilize various trusts to minimize estate tax liability as well as provide assistance or management for the surviving family.
In a study of men with metastatic castration-resistant prostate cancer, the novel investigational agent OGX-011 showed a trend for overall survival while only modestly affecting PSA levels.
A recent study designed to determine the efficacy of intravesical botulinum toxin in patients with neurogenic detrusor overactivity and urinary incontinence secondary to spinal cord injury or multiple sclerosis showed positive results.
What advantages and challenges do you see with multi- and single-generation practices?
Neuropathic changes as seen on quantitative electromyography (EMG) have been found to more accurately reflect the neuromuscular integrity of the muscle under study by recording electrical activity of nearby motor units.
In this interview, Gopal H. Badlani, MD, discusses the shift to mid-urethral sling placement, the growth of synthetic graft materials, and the reasons for these changes in the management of female stress urinary incontinence.
A pair of recent studies using imaging technology to pinpoint areas of the brain relevant to urinary continence signal a noteworthy new research direction examining the critical role the brain-bladder network plays in urinary continence.
If you are serious about improving performance and increasing the level of service provided in your urology practice, it's critical to follow some basic tenets: stay informed, monitor performance, provide leadership and direction, and maintain accountability.
Post-prostatectomy patients with undetectable PSA levels but who have high-risk features in the prostatectomy specimen can delay biochemical progression by undergoing immediate radiotherapy (RT) rather than waiting for salvage radiotherapy once it occurs.
No matter the size of your practice, unless each physician is the same age and plans to retire at the same time, you should consider developing a transition plan for the senior doctors in your practice.
Intravesical gene therapy with adenoviral-mediated interferon-alpha (Roferon A) led to complete responses in almost half of patients with bacillus Calmette-Guérin (BCG)-refractory transitional cell bladder cancer.
New products and services from Medison, RemedyMD, BSU Enterprises, Inc., Cook Medical, and Medtronic, Inc.
Stress is a key component of functional urinary tract disorders and plays a critical role in the exacerbation, and perhaps development, of urinary tract conditions such as overactive bladder and interstitial cystitis/painful bladder syndrome (IC/PBS).
A 9-month delay in diagnosis of bladder cancer after a first hematuria diagnosis significantly increases mortality risk.
This review focuses on the clinical evidence supporting three nonsurgical treatments for BPH/LUTS in development: phosphodiesterase type-5 inhibitors, the intraprostatic instillation of onabotulinumtoxinA (BTA [Botox]), and gonadotropin-releasing hormone (GnRH) antagonists.
Italian researchers say they have some direct evidence for central sensitization in interstitial cystitis/painful bladder syndrome (IC/PBS).
Systematic reviews and abstracts for randomized controlled trials (RCTs) appearing in the urologic literature are generally of less than optimal quality, say researchers from the University of Florida College of Medicine, Gainesville.
It is vital for urologists to take time out of their busy day to contact committee chairs and committee members or, better yet, testify when a bill in committee affects how urologists treat their patients.